Health Alabama’s child COVID hospitalizations hit another record, four on ventilators Of the 97 children hospitalized with COVID-19 on Monday, 15 were in ICUs and four on ventilators. Eddie BurkhalterJanuary 18, 2022
Health Alabama setting record numbers of child COVID hospitalizations UAB's Dr. Michael Saag said child hospitalizations could be increasing due to the record numbers of cases the state is seeing. Eddie BurkhalterJanuary 14, 2022
Health Alabama’s average daily reported COVID cases breaks 10,000 for first time Alabama’s COVID hospitalizations reached 1,776 on Monday, a level not seen since Sept. 21 and a 239 percent increase from two weeks ago. Eddie BurkhalterJanuary 11, 2022
Health Alabama hospitals, schools react as COVID surges While some public school systems are requiring masks, others are taking a wait-and-see approach as cases and hospitalizations increase statewide. Eddie BurkhalterJanuary 10, 2022
Health Alabama seeing record new COVID cases, hospitalizations continue rising Treatments for the more contagious omicron variant are in short supply in Alabama as COVID cases surge and hospitalizations grow. Eddie BurkhalterJanuary 5, 2022
Health Shipments of treatments for delta resume as COVID surges A new monoclonal antibody treatment effective against the omicron variant isn't yet available in Alabama as cases and hospitalizations rise. Eddie BurkhalterJanuary 3, 2022
Health COVID rising across Alabama The percentage of COVID tests in Alabama that are positive reached 18.2 percent on Sunday. Eddie BurkhalterDecember 28, 2021
Health Alabama’s positivity rate rising sharply as cases begin to increase Alabama's percent of tests that are positive increased by 76 percent over two weeks. New cases and hospitalizations are rising as well. Eddie BurkhalterDecember 24, 2021
Health Feds pause shipments of two monoclonal antibody treatments, ineffective against omicron The drugs were critical in preventing hospitalizations and deaths during the delta surge. Eddie BurkhalterDecember 24, 2021
Health FDA approves second antiviral COVID pill Merck’s drug, molnupiravir, was found to reduce hospitalizations and deaths by 30 percent, while Pfizer's antiviral pill had a nearly 90 percent reduction. Eddie BurkhalterDecember 24, 2021